Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

New MMP inhibitors reported by Warner-Lambert

Jan. 31, 1997

Takeda researches follow-up compounds to leuprorelin

Jan. 31, 1997

Astra investigates H. pylori vaccines

Jan. 31, 1997

Serine protease inhibitors reported by Akzo Nobel

Jan. 31, 1997

Pfizer reveals agents for hypercholesterolemia, atherosclerosis

Jan. 30, 1997

Microcide reports new cephalosporin antibiotics

Jan. 30, 1997

Cortex claims AMPA receptor modulators for CNS disorders

Jan. 30, 1997

Synthelabo investigates oxazolidinones

Jan. 30, 1997

New steroidal anesthetics from Akzo Nobel

Jan. 30, 1997

N-oxide antibacterial compounds from Bayer

Jan. 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.